SCHEMBL29014895

SCHEMBL29014895

C[C@@H](O)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 2/20 0.53
▸ NPY1R P25929 1/20 0.53
▸ NPY2R P49146 1/20 0.53
▸ ERAP2 Q6P179 1/20 0.52
▸ LNPEP Q9UIQ6 1/20 0.52
▸ ENPEP Q07075 2/20 0.50
▸ NTSR2 O95665 2/20 0.49
▸ NTSR1 P30989 2/20 0.49
▸ GNPAT O15228 1/20 0.48
▸ CHRND Q07001 6/20 0.47
▸ CHRNA1 P02708 2/20 0.47
▸ CHRNG P07510 2/20 0.47
▸ CHRNB1 P11230 2/20 0.47
▸ MME P08473 2/20 0.47
▸ ACE P12821 2/20 0.47
▸ CPA1 P15085 1/20 0.47
▸ ACE2 Q9BYF1 1/20 0.47
▸ NPPA P01160 1/20 0.47
▸ ECE1 P42892 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29014899 1.00 NPY4R (0.53) NPY4RNPY1RNPY2RERAP2LNPEP
SCHEMBL29349493 0.96 NPY4R (0.55) NPY4RNPY1RNPY2RERAP2LNPEP
SCHEMBL30657434 0.95 NPY1R (0.49) NPY4RNPY1RNPY2RERAP2LNPEP
SCHEMBL30433385 0.92 NPY4R (0.54) NPY4RNPY1RNPY2RERAP2LNPEP
SCHEMBL30810206 0.92 NPY4R (0.52) NPY4RNPY1RNPY2RERAP2LNPEP
SCHEMBL29808027 0.91 GNPAT (0.58) ERAP2LNPEPGNPATECE1
SCHEMBL30575177 0.90 NPY1R (0.56) NPY4RNPY1RNPY2RERAP2LNPEP
SCHEMBL30882728 0.89 MME (0.50) NPY4RNPY1RNPY2RMMEACE
SCHEMBL30123042 0.89 MME (0.58) NPY4RNPY1RNPY2RENPEPMME
SCHEMBL31181212 0.87 GNPAT (0.54) ERAP2LNPEPGNPAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116087353-B Metabolic identification method for wild cordyceps sinensis and substitute thereof 武汉大学中南医院 2025-04-08 — — CN claimed
CN-116087353-A Metabolic identification method for wild cordyceps sinensis and substitute thereof 武汉大学中南医院 2023-05-09 — — CN claimed
CN-116087353-B Metabolic identification method for wild cordyceps sinensis and substitute thereof 武汉大学中南医院 2025-04-08 — — CN disclosed
CN-117425498-A Novel peptide conjugates 艾缇亚(上海)制药有限公司 2024-01-19 — — CN disclosed
US-20230331792-A1 NEW MULTI-FUNCTIONAL OLIGOPEPTIDES Enlitisa (Shanghai) Pharmaceutical Co., Ltd. (CN) 2023-10-19 — — US disclosed
CN-114350646-B UDP-sugar epimerase PsUGE2 and application thereof in synthesis of arabinoside 北京理工大学 2023-08-29 — — CN disclosed
CN-116087353-A Metabolic identification method for wild cordyceps sinensis and substitute thereof 武汉大学中南医院 2023-05-09 — — CN disclosed
CN-114350646-A UDP-sugar epimerase PsUGE2 and application thereof in arabinoside synthesis 北京理工大学 2022-04-15 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331792-A1 NEW MULTI-FUNCTIONAL OLIGOPEPTIDES VIP, MLX, IAPP NPY4R 103/4885NPY1R 75/4885NPY2R 183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback